Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE
Improvement in NPS was associated with improvements in PNIF and patient-reported outcomes irrespective of treatment. PNIF could be a useful noninvasive tool for monitoring nasal polyp size.
Authors
- Peter W. Hellings (ORCID: https://orcid.org/0000-0001-6898-688X)
- Amber Luong (ORCID: https://orcid.org/0000-0001-6078-8010)
- Robert Chan (ORCID: https://orcid.org/0009-0000-2636-6762)
- Ludger Klimek (ORCID: https://orcid.org/0000-0002-2455-0192)
- Abby Fuller
- Richard J. Harvey (ORCID: https://orcid.org/0000-0002-6942-8975)
- Jared Silver (ORCID: https://orcid.org/0000-0002-7838-0985)
- Joshua M. Levy (ORCID: https://orcid.org/0000-0001-5907-3421)
- Steven G. Smith (ORCID: https://orcid.org/0000-0001-9928-117X)
Institutions
- Emory University (US)
- Clinical Research Institute (US)
- Zentrum für Rhinologie und Allergologie (DE)
- GlaxoSmithKline (Germany) (DE)
- The University of Texas Health Science Center (US)
- Macquarie University (AU)
- KU Leuven (BE)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.jacig.2024.100327
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline